Blog - Page 3777 of 5482

TuesdayDec 22, 2009 3:32 pm

eDoorways Corp. (EDWY.PK) Meets Requirements to Resolve Caveat Emptor

eDoorways Corp.’s Director of Operations, Lance Kimmons, announced today that the company completed filing all of what appears to be required for OTC/Pinksheets and its website. "The information required for the Pinksheets is rather extensive and exhaustive," stated Lance Kimmons. "Much like the SEC audit, the information requested was in depth and in some instances very specific to Pinksheets." "As I reported last week, initially we immediately reapplied to the Pinksheet website via the OTC Disclosure and News Service. We then executed the OTC I.Q. Agreement for OTCIQ.com and paid the $500 application fee along with the $3,000 annual fee.…

TuesdayDec 22, 2009 3:17 pm

Muscle Flex, Inc. (MFLI.PK) Details Its Online Marketing Strategy for VATA Brasil Sports & Active Wear Collection for Women

Muscle Flex Inc. provided investors with details regarding its online marketing strategy for its Muscle Flex VATA Brasil(TM) Sports and Active Wear Collection planned for January 2010. The company aims to initially launch the Muscle Flex VATA Brasil line with a focused and targeted online campaign that will include a number of component parts to market the brand directly to a female fitness audience from ages 25-55. Muscle Flex’s strategy has been designed to achieve the following: 1. Increase search rankings on all major search engines for the key words associated with female fitness which includes: female fitness, workout apparel,…

TuesdayDec 22, 2009 1:21 pm

Derma Sciences Inc. (DSCI.OB) Completes Worldwide Licensing Agreement for Honey-Based Wound Care Technology

Derma Sciences Inc. is a specialty medical device and pharmaceutical company focusing on advanced wound care. The company today announced it has completed an agreement with healthcare product and life science company Comvita New Zealand Ltd. for the worldwide licensing rights for Derma Sciences’ MEDIHONEY wound and skin care products. Comvita dominates worldwide honey production, controlling about 75 percent of global Leptospermum (manuka) honey production, and is the owner of key intellectual property and patents concerning the use of honey in medical dressings. Derma Sciences currently has licensing rights for North and South America only – about one-third of the…

TuesdayDec 22, 2009 1:19 pm

Genoil Inc. (GNOLF.OB) Provides 2009 Shareholder Update; Announces Significant Milestones

Genoil Inc. is a Canada-based international engineering technology development company with innovative hydrocarbon, oil and water separation and maritime technologies. The company today updated its shareholders on the progress made in 2009 and announced that it has received notification from the U.S. Patent Office that it has been allowed its first patent for its sand decontamination technology. Genoil’s sand decontamination technology is designed to clean sand for use in concrete mixing, construction, and for the development of beaches. The company said it anticipates its patent will be granted by the U.S. Patent Office before March 8, 2010. In the press…

TuesdayDec 22, 2009 1:15 pm

Gulf Resources, Inc. (GFRE) Closes $25 Million Private Placement Transaction

Gulf Resources Inc. operates through two wholly-owned subsidiaries, Shouguang City Haoyuan Chemical Company and Shouguang Yuxin Chemical Industry. The company believes that it is one of the largest producers of bromine and crude salt in China. Bromine is used to manufacture a wide variety of compounds utilized in industry and agriculture. Through its Shouguang Yuxin Chemical subsidiary, Gulf Resources manufactures specialty chemical products utilized in a variety of applications, including oil & gas field explorations and papermaking. Gulf Resources today announced that on December 22, 2009 it closed a private placement financing which was previously announced on December 11, 2009.…

TuesdayDec 22, 2009 1:13 pm

Shire plc (SHPGY) Submits License Application for REPLAGAL®

Shire plc, a global specialty biopharmaceutical company, today announced that it has submitted a Biologics License Application (BLA) with the FDA for REPLAGAL®, the company’s enzyme replacement therapy for Fabry disease. REPLAGAL first received marketing authorization in the EU in 2001, and is approved for the treatment of Fabry disease in 45 countries. Fabry disease is a rare X-linked recessive (inherited) lysosomal storage disease that can cause a wide range of systemic symptoms. The disease interferes with the body's ability to break down a specific fatty substance (globotriaosylceramide or Gb3) which accumulates within the body due to deficiency of a…

TuesdayDec 22, 2009 1:06 pm

November Existing Home Sales Soar 7.4 Percent

After surging 10% in October, sales of existing homes jumped again in November rising by 7.4%. The level of existing home sales hit the highest level since February 2007, a sign that perhaps the housing market is gaining strength. Sales are now up 46 percent from the bottom in January, but still down 10 percent from the peak more than four years ago. The surprisingly strong sales figures were spurred in large part by low interest rates and first-time home buyers looking to take advantage of the $8,000 federal tax credit. About 2 million homebuyers have taken advantage of the…

TuesdayDec 22, 2009 12:09 pm

A-Power Energy Generation Systems, Ltd. (APWR) Signs $86M Contract with Thailand’s Biomass Electricity to Construct a 150MW Biomass Plant

A-Power Energy Generation Systems, Ltd., China’s biggest distributed energy (DG) systems provider, revealed today the signing of a major DG contract with Thailand's Biomass Electricity Co., Ltd. (TBE) to construct a 150-megawatt (MW) biomass plant in Prachinburi, approximately 75 miles east of Thailand’s capital Bangkok. The Company brings its vast knowledge of DG systems engineering, as evinced by its extant projects and recent major foray into wind turbine manufacturing, to bear squarely on Thailand’s growing demand for environmentally-friendly energy. The biomass plant contract encompasses all major aspects of execution, from design to the procurement and installation of the three main…

TuesdayDec 22, 2009 10:15 am

SCI Engineered Materials, Inc. (SCIA.OB) Awarded Grant to Commercialize Products for Solar Industry

SCI Engineered Materials, Inc. announced today that it has been awarded $775,400 by the Ohio Department of Development's Ohio Third Frontier Photovoltaic Program (OTFPVP). The grant was awarded for the commercialization of advanced technology for high power density rotatable ceramic sputtering targets. These targets are used to manufacture thin film photovoltaic solar cells. The award is still subject to State of Ohio Controlling Board approval. Scott Campbell, Ph.D., Vice President of Technology, stated, "We are pleased to have been selected by Ohio's Third Frontier Photovoltaic Program to help commercialize the high power density ceramic sputtering target attachment technology that SCI…

TuesdayDec 22, 2009 9:56 am

BIO-key International, Inc. (BKYI.OB) Announces Appointment of Cecilia Welch as Chief Financial Officer

BIO-key International, Inc., a leading developer of advanced finger-based biometric identification solutions, recently announced the appointment of Cecilia Welch as the company’s vice president and chief financial officer, replacing chairman Tom Colatosti, who had been serving as the interim chief financial officer. Previously serving as BIO-key International’s corporate controller since 2007, Ms. Welch has more than 20 years of financial management experience in the technology industry. Prior to her role at BIO-key, Ms. Welch held the position of controller for other leading technology-based companies, including Savaje Technologies, Crystal Systems and ATN Microwave (acquired by Agilent Technologies). Ms. Welch earned her…

Site Search

Company Search